BioPorto A/S: Implementation of capital reduction and consequent adjustment of conversion price for convertible debt instruments

At the company's annual general meeting on 16 April 2013, it was decided to reduce the company's share capital from DKK 141,449,052 to DKK 47,149,684 by reduction of the nominal value of the company's shares from DKK 3 to DKK 1 per share.

The statutory notice period of four weeks after the decision, has now expired and, today, the implementation of the reduction of the share capital has been registered with the Danish Business Authority. Hereafter, the company's share capital amounts to nominally DKK 47,149,684, corresponding to 47,149,684 shares of DKK 1 each

As a consequence of the share capital decrease the conversion price for the convertible debt instruments issued by the company and listed on NASDAQ OMX Copenhagen under ISIN DK0030263454 is adjusted to DKK 6.76 per share with a nominal value of DKK 1.

The company's articles of association have been amended as a consequence of the reduction of the capital. The amended articles of association can be found on the company's website.

Gentofte, May 21, 2013.

BioPorto A/S

The Board of Directors

Further information:

Christina Thomsen, Investor Relations

Thea Olesen, CEO

Tel. no. ([phone], e-mail: [e-mail]

Attachment:
https://newsclient.omxgroup.com/cds/DisclosureAttachmentServlet?messageAttachmentId=433464